Bridgeway Capital Management’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-231,000
Closed -$2.1M 1427
2020
Q4
$2.1M Hold
231,000
0.04% 502
2020
Q3
$1.41M Hold
231,000
0.03% 546
2020
Q2
$2.05M Hold
231,000
0.04% 408
2020
Q1
$1.68M Hold
231,000
0.04% 392
2019
Q4
$2.04M Hold
231,000
0.03% 545
2019
Q3
$1.41M Hold
231,000
0.02% 630
2019
Q2
$966K Buy
+231,000
New +$1.22M 0.01% 748
2019
Q1
Sell
-105,000
Closed -$680K 1421
2018
Q4
$680K Hold
105,000
0.01% 903
2018
Q3
$872K Hold
105,000
0.01% 940
2018
Q2
$654K Buy
+105,000
New +$668K 0.01% 1044
2017
Q1
Sell
-50,000
Closed -$541K 1492
2016
Q4
$541K Hold
50,000
0.01% 1062
2016
Q3
$817K Sell
50,000
-450
-0.9% -$6.33K 0.01% 884
2016
Q2
$481K Sell
50,450
-197,800
-80% -$2.15M 0.01% 1067
2016
Q1
$3.48M Sell
248,250
-28,078
-10% -$291K 0.06% 315
2015
Q4
$3M Sell
276,328
-168,872
-38% -$1.53M 0.06% 348
2015
Q3
$3.03M Buy
445,200
+28,000
+7% +$217K 0.06% 328
2015
Q2
$3.81M Buy
417,200
+270,200
+184% +$2.05M 0.08% 295
2015
Q1
$992K Hold
147,000
0.02% 790
2014
Q4
$497K Buy
147,000
+40,000
+37% +$128K 0.01% 1066
2014
Q3
$358K Hold
107,000
0.01% 1218
2014
Q2
$445K Sell
107,000
-96,900
-48% -$513K 0.01% 1144
2014
Q1
$1.62M Buy
203,900
+30,189
+17% +$225K 0.05% 560
2013
Q4
$1.23M Buy
173,711
+3,511
+2% +$23.4K 0.04% 673
2013
Q3
$1.26M Buy
170,200
+62,900
+59% +$490K 0.04% 625
2013
Q2
$932K Buy
+107,300
New +$690K 0.04% 669

Other funds holding NPTN

Bridgeway Capital Management's NPTN Position: Q1 2021 in Review

Bridgeway Capital Management sold out of NEOPHOTONICS CORP (NPTN) in Q1 2021, closing a stake of 231,000 shares — an estimated $2.1M sold.

Bridgeway Capital Management first reported a position in NPTN in Q2 2013 and held it in 25 quarters. The position peaked at $3.81M in Q2 2015. 147 funds tracked by Wall St. Rank hold NPTN as of Q1 2021.

  • Bridgeway Capital Management reported no remaining NEOPHOTONICS CORP position as of Q1 2021 after selling out during the quarter.
  • Bridgeway Capital Management sold 231,000 NEOPHOTONICS CORP shares in Q1 2021, an estimated $2.1M.
  • Bridgeway Capital Management first reported a position in NEOPHOTONICS CORP in Q2 2013 and held it in 25 quarters.
  • Bridgeway Capital Management's NEOPHOTONICS CORP position peaked at $3.81M in Q2 2015.
  • 147 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q1 2021.

Based on Bridgeway Capital Management's 13F filing for Q1 2021, filed 17 May 2021.